Abstract
Alzheimer's disease is a neurodegenerative disease in which progressive memory loss occurs and presents cognitive symptoms. Currently, the number of studies with Cannabidiol as a treatment alternative for Alzheimer's disease is growing due to its neuroprotective factor. Research indicates that cannabidiol has the ability to control microglial and neuroinflammation function, favoring the survival rate of cells by combining its anti-inflammatory, antioxidant and neuroprotective effects, which act against toxicity caused by the accumulation of beta-amyloid peptides.
DOI: https://doi.org/10.56238/tfisdwv1-128